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SYNOPSIS
      
	Gene therapy uses genes as medicine and is a promising approach for the treatment of genetic defects as well as many acquired diseases. It involves transfer of a normal functioning copy of a non-functional gene into our body cells in order to repair the faulty gene. Putting it differently, this therapeutic modality replaces a faulty gene or introduces a new gene whose function is to cure or to favorably modify the clinical course of a disease. However, this is easier said than done. Since both the macromolecular nucleic acids (genes) and the biological cell surfaces are negatively charged, spontaneous entry of naked genes into body cells is unlikely to be an efficient process.  This is why developing a promising gene therapeutic approach and designing safe and efficient gene delivery reagents are two inseparable problems.
   
The success of gene therapy critically depends on the efficiency with which the functioning copy of the genes is delivered into our body cells. Broadly speaking, two methods are used for delivering genes. One is viral gene delivery and the other is non-viral gene delivery. In general, the transfection efficiencies of viral vectors are higher than their non-viral counterparts. The exquisite natural ability of viruses to transfer their genetic payload into humans has inspired scientists to use viruses for delivering therapeutic genes in gene therapy. However, there are practical limitations of viral gene delivery systems including difficulties of their large scale production, lack of selectivity, insertional mutagenesis, and immunogenic responses raised against virus structural components etc. All these alarming bio-safety concerns associated with the use of viral vectors are increasingly making the non-viral gene delivery reagents as the alternative vectors of choice. Non-viral methods include DNA delivery using physical and chemical methods. Among the existing arsenal of non-viral gene delivery reagents, the distinct advantages associated with the use of cationic liposomes (used generally in combination with neutral molecules like cholesterol, DOPC or DOPE) as gene carrier include their robust manufacture, ease in handling and preparation techniques, ability to inject large lipid-DNA complex and low immunogenic response. 

       Cationic lipid molecules are amphiphilic in nature containing a lipid anchor, a linker group, and a positively charged head group. These are soluble in organic solvents such as chloroform and methanol, and are usually dissolves as monomers in these organic solvents. However, when dissolved in water these cationic amphiphiles spontaneously form multilamellar vesicular structures (MLV) called liposomes above a certain critical vesicular concentration (CVC). On sonication or extrusion through various pore size membranes, the multilamellar liposome (MLV) assumes the size of small unilamellar vesicle (SUV, 20-100 nm) or large unilamellar vesicle (LUV, 150-250 nm) respectively (Figure 1).


         The transfer of DNA (containing the gene of interest) into a cell with the subsequent expression of its encoded protein is called “transfection”. In liposomal gene delivery, cationic liposomes are mixed with DNA and the resultant lipid-DNA complexes (popularly known as lipoplexes) are simply incubated with the cells (in vitro) or injected intravenously (in vivo). The intracellular transfection pathway in lipoplex mediated transgene expression consists mainly of three steps: initial endocytotic cellular uptake of lipoplex by plasma membrane; escape of DNA from the endosome (endosomal release) into the cell cytoplasm and efficient transport of the endosomally released DNA to the cell nucleus (Figure 2). If the DNA (containing the gene of interest) is taken up by cells and eventually reaches the nucleus, the encoded protein gets finally expressed through transcription and translation. Quantitative assay of the expressed protein indicates the degree of efficiency of the transfection procedure.

                              Figure 2: Lipofection pathway.
         
         The transfection efficiency of any given liposomal formulation is highly dependent on the cell line, type of cationic lipid and the ratio of lipid:DNA. Interestingly majority of the efficient contemporary cationic amphiphiles such as, DOTMA, DMDHP, DMRIE, etc. (Figure 3) possess a common structural element in their molecular architecture, namely a glycerol backbone (highlighted by the rectangular boxes in figure 3) linking the cationic head-group and the hydrophobic tail region. Covalent grafting of hydroxyl moiety in the head group region of cationic lipids has been demonstrated to be capable of imparting efficient transfection properties of cationic lipids.  It was suggested that the hydroxyl group could improve the compaction of DNA by several mechanisms. For example, DNA can form hydrogen bonds with the lipids, and the hydroxyl group can enhance the membrane hydration. Detailed structure-activity investigations in cationic lipid mediated gene delivery using such glycerol based cationic transfection lipids with varying chain lengths hydrophobic tails, ether linker regions, unsaturated hydrophobic tails with membrane reorganizing capabilities etc. have been reported. The corresponding structure-activity studies using non-glycerol based cationic transfection lipids have previously been reported from our lab.



                    




Figure 3: Representative structures of Glycerol based cationic lipids with Hydroxyalkyl head group.      




Present Thesis.
       The molecular architectures of cationic amphiphiles consist of a positively charged water-loving polar head-group region and a non-polar hydrophobic tail region (usually consisting of either two long aliphatic hydrocarbon chains or a cholesterol skeleton) often tethered together via a linker functionality such as ether, ester, amide, amidine group, etc.  Understanding the structural parameters capable of influencing the gene delivery efficiencies of cationic transfection lipids is important. To this end, the focus of many prior structure-activity investigations have been centered around probing the influence of each of the above mentioned three lipid structural components in modulating the gene transfer efficacies of cationic amphiphiles.  For instance, a number of prior reports have demonstrated that the gene transfer efficiencies of cationic amphiphiles critically depends on their molecular architectures including hydrophobic alkyl chain-lengths, nature of head-groups as well as on the nature of linker and spacer functionalities used in covalent tethering of the polar head-groups and the non-polar tails of cationic amphiphiles. Toward probing the hitherto unexplored influence of linker orientation in cationic lipid mediated gene delivery, we have designed & synthesized two structurally isomeric remarkably similar cationic amphiphiles 1 & 2 (Figure 4) bearing the same hydrophobic tails and the same polar head-groups connected by the same ester linker group.  The only structural difference between the cationic amphiphiles 1 & 2 is the orientation of their linker ester function. Synthesis, dramatic contrasting in vitro gene delivery efficacies and physiochemical properties of these novel cationic lipids are described in Chapter 1. 


Figure 4. Structure of two cationic amphiphiles differing only in linker orientation
Transfection efficacies of the Lipids 1& 2 were checked in COS-1 (SV 40 transformed African green monkey kidney cells), CHO (Chinese hamster ovary cells), HepG2 (Human hepatocarcinoma) and A549 (human lung carcinoma cells) using p-CMV-SPORT-β-gal plasmid DNA. While lipid 1 showed high efficacies in delivering reporter genes into multiple cultured mammalian cells including CHO, COS-1, HepG2 and A549, lipid 2 was found to be essentially incompetent in transferring genes into any of these cells. To obtain deeper insights into the origin of poor gene transfer efficacies of cationic transfection lipid 2, we have conducted differential scanning calorimetry, fluorescence anisotropy and conventional dye entrapment experiments. Our findings are consistent with the supposition that the significantly more membrane fluidity of the lipid 1 liposomes than that of lipid 2 liposomes are likely to play a dominant role behind the strikingly superior transfection efficacies of lipid 1.
 
	Many previous reports shown that, cationic liposomes bearing various covalently grafted cell specific ligands (the so-called “homing” device) are capable of delivering their genetic pay-loads to specific body cells.  To this end, perhaps, the most elegant uses of cationic transfection lipids have been demonstrated for targeting genes to liver cells (hepatocytes). Hepatocytes over express the high affinity cell-surface receptors that can bind asialoglycoproteins and then internalize them into the cell cytoplasm. Interestingly, design of many of the previously reported liver-specific cationic glycol-lipid based tranfection vectors has been based on the covalent grafting of only the cyclic pyranose form of D-galactose (the high affinity ligand for asialoglycoprotein receptors) into their polar head-group regions.  To this end, inspired by our previous findings that cationic glycolipids with open-sugar heads are also capable of efficiently transfecting cultured cells in vitro, I have addressed an yet unexplored structure-function issue in the area of cationic glycol-lipid mediated gene delivery namely, “Does the polar sugar-head of the galactosylated cationic lipids necessarily need to be in the cyclic pyranose forms?”. Toward finding an answer, I have designed and synthesized two novel series of cationic glycoamphiphiles 1-5 and 6-10 (Figure 5) containing the cyclic- and open-galactose heads respectively, at increasing covalent bond distances from the quaternary nitrogen centers and evaluated their relative in vitro efficiencies in transfecting five cultured mammalian cells including human hepatocarcinoma (HepG2) and human lung carcinoma (A549) cells. As delineated in chapter 2, the cationic glycol-lipids 3 (pyranose form) and 6 (acyclic form) to be the most promising cationic glycol-lipids.  The cellular uptake of the lipid:DNA complexes for both the glycol-lipids 3 & 6 were found to be mediated through asialoglycoprotein receptors in both cultured HepG2 and primary hepatocytes. Importantly, the in vitro transfection efficacies of the glyco-lipids 3 and 6 were also found to be highly serum compatible (up to 60% added serum). Finally, towards probing the systemic potentials of these two most promising cationic glycol-lipids (3 & 6), the lipid:DNA complexes were intravenously injected in C57 balbC mice and degree of transfection in various organs including lung, liver, heart, spleen and kidney were measured.  Contrary to usual high lung transfection efficacies of cationic lipids, both the lipids failed in transfecting mouse lungs and instead exhibited remarkable liver specificity. Thus, the novel cationic glycolipids 3 & 6 hold promise for future use in liver-specific systemic gene delivery.





    








Figure 5: Chemical structures of glycolipids with cyclic and open of the sugar heads.
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